Back to Matthew McLennan
Matthew McLennan → RPRX via First Eagle Investment Management, LLC
Matthew McLennan RPRX Position History
Royalty Pharma plc
Quarters held
8
Latest value
$1.3B
Q2 2026
Peak value
$1.4B
First seen
Q1 2026
Quarter-by-quarter history
Every disclosed snapshot
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $1.3B | 28.33M | — | — |
| Q2 2026 | $27.1M | 583.9K | — | — |
| Q2 2026 | $1.3B | 28.33M | — | — |
| Q2 2026 | $27.1M | 583.9K | — | — |
| Q1 2026 | $1.4B | 27.83M | — | — |
| Q1 2026 | $27.9M | 543.3K | — | — |
| Q1 2026 | $1.4B | 27.83M | — | — |
| Q1 2026 | $27.9M | 543.3K | — | — |